Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
Article Information
History
- December 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mary K. Young1,
- Christine Kornmeier2,
- Rebecca M. Carpenter1,
- Nick R. Natale3,
- Jennifer M. Sasson1,
- Michael D. Solga4,
- Amy J. Mathers1,
- Melinda D. Poulter6,
- Xiao Qiang2 and
- William A. Petri Jr.1,5,6,^
- 1Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA
- 2MilliporeSigma, St. Louis, MO, 63103, USA
- 3Department of Neuroscience, University of Virginia Health System, Charlottesville, VA, 22908, USA
- 4UVA Flow Cytometry Core, University of Virginia, Charlottesville, VA, 22908, USA
- 5Department of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA, 22908, USA
- 6Department of Pathology, University of Virginia Health System, Charlottesville, VA, 22908, USA
- ↵^Corresponding author; email: wap3g{at}virginia.edu
Posted December 07, 2020.
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos